These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 31230675)

  • 21. [Controlled tapering of medication. What do structured treatment withdrawal achieve?].
    MMW Fortschr Med; 2000; 142(3 Suppl):25-6. PubMed ID: 10893958
    [No Abstract]   [Full Text] [Related]  

  • 22. Withdrawal syndrome with gradual tapering of alprazolam.
    Mellman TA; Uhde TW
    Am J Psychiatry; 1986 Nov; 143(11):1464-6. PubMed ID: 3535544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine agonist withdrawal syndrome: A comprehensive review.
    Yu XX; Fernandez HH
    J Neurol Sci; 2017 Mar; 374():53-55. PubMed ID: 28104232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Withdrawal symptoms after graduated cessation of imipramine in children.
    Law W; Petti TA; Kazdin AE
    Am J Psychiatry; 1981 May; 138(5):647-50. PubMed ID: 7235061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of triazolam dependence with a tapering withdrawal regimen.
    Singh AN; Chemij M; Jewell J
    CMAJ; 1986 Feb; 134(3):243-5. PubMed ID: 3942931
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of a high-dose fast tapering buprenorphine detoxification program on symptom relief and treatment retention.
    Palmstierna T
    J Psychoactive Drugs; 2004 Jun; 36(2):273-7. PubMed ID: 15369209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gamma-hydroxybutyrate detoxification by titration and tapering.
    de Jong CA; Kamal R; Dijkstra BA; de Haan HA
    Eur Addict Res; 2012; 18(1):40-5. PubMed ID: 22142784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective study of scheduled withdrawal from nortriptyline in children and adolescents.
    Geller B; Cooper TB; Carr LG; Warham JE; Rodriguez A
    J Clin Psychopharmacol; 1987 Aug; 7(4):252-4. PubMed ID: 3624507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review.
    Fava GA; Benasi G; Lucente M; Offidani E; Cosci F; Guidi J
    Psychother Psychosom; 2018; 87(4):195-203. PubMed ID: 30016772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review.
    Fava GA; Gatti A; Belaise C; Guidi J; Offidani E
    Psychother Psychosom; 2015; 84(2):72-81. PubMed ID: 25721705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carisoprodol withdrawal syndrome.
    Reeves RR; Beddingfield JJ; Mack JE
    Pharmacotherapy; 2004 Dec; 24(12):1804-6. PubMed ID: 15585447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxcarbazepine in rapid benzodiazepine detoxification.
    Croissant B; Grosshans M; Diehl A; Mann K
    Am J Drug Alcohol Abuse; 2008; 34(5):534-40. PubMed ID: 18821451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Taperingstrips for paroxetine and venlafaxine].
    Groot PC;
    Tijdschr Psychiatr; 2013; 55(10):789-94. PubMed ID: 24194351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-patient benzodiazepine withdrawal: comparison of fixed and symptom-triggered taper methods.
    McGregor C; Machin A; White JM
    Drug Alcohol Rev; 2003 Jun; 22(2):175-80. PubMed ID: 12850904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Withdrawal symptoms in critically ill children after long-term administration of sedatives and/or analgesics: a first evaluation.
    Ista E; van Dijk M; Gamel C; Tibboel D; de Hoog M
    Crit Care Med; 2008 Aug; 36(8):2427-32. PubMed ID: 18596622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Venlafaxine withdrawal syndrome.
    Sabljić V; Ružić K; Rakun R
    Psychiatr Danub; 2011 Mar; 23(1):117-9. PubMed ID: 21448114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benzodiazepines for panic disorder. Are they safe?
    Garvey M
    Postgrad Med; 1991 Oct; 90(5):245-6, 249-52. PubMed ID: 1681526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Withdrawal of antiepileptic drugs during presurgical video-EEG monitoring: an observational study for evaluation of current practice at a referral center for epilepsy.
    Henning O; Baftiu A; Johannessen SI; Landmark CJ
    Acta Neurol Scand; 2014 Apr; 129(4):243-51. PubMed ID: 23980664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Slow tapering from methadone maintenance in a program encouraging indefinite maintenance.
    Calsyn DA; Malcy JA; Saxon AJ
    J Subst Abuse Treat; 2006 Mar; 30(2):159-63. PubMed ID: 16490679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe vasculonecrotic erythema nodosum leprosum following thalidomide withdrawal without tapering doses: do we have something unusual?
    Mahajan VK; Chauhan PS; Sharma NL; Sharma AL; Mehta KS
    Braz J Infect Dis; 2011; 15(1):90-1. PubMed ID: 21412598
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.